Hamaui Cuadrado S, Guinart Vidal M
Clarivate Analytics, Barcelona, Spain.
Drugs Today (Barc). 2018 May;54(5):335-341. doi: 10.1358/dot.2018.54.5.2828185.
The Drug Information Association (DIA) Europe held its annual meeting from April 17-19, 2018, in Basel, Switzerland. The key topics discussed in the 3-day meeting were related to pharmacovigilance, clinical development, patient engagement, data and data standards, preclinical development and early-phase clinical research, regulatory science, translational medicine and science, and value and access. The program was principally focused on the current opportunities and future landscape of the healthcare system as a result of the increasingly innovative technologies and effective utilization of big data. In addition, the critical need for collaboration and partnership between all the stakeholders of the healthcare system was highlighted. This report covers some of the regulatory sessions presented at the meeting in which regulators, payers, industry and patients presented their perspectives for discussion.
药物信息协会（DIA）欧洲分会于2018年4月17日至19日在瑞士巴塞尔举行了年度会议。在为期三天的会议中讨论的关键主题涉及药物警戒、临床开发、患者参与、数据及数据标准、临床前开发和早期临床研究、监管科学、转化医学与科学，以及价值与可及性。该会议主要聚焦于由于日益创新的技术和大数据的有效利用而给医疗保健系统带来的当前机遇和未来前景。此外，还强调了医疗保健系统所有利益相关者之间开展合作与伙伴关系的迫切需求。本报告涵盖了会议上的一些监管环节，监管机构、支付方、行业和患者在这些环节中阐述了各自的观点以供讨论。
